Aster DM Merger: 97% Shareholder Approval Paves Way for Top 3 Hospital Chain

Introduction: A Major Step Towards Consolidation

Aster DM Healthcare Limited has achieved a critical milestone in its plan to merge with Quality Care India Limited (QCIL), securing overwhelming approval from its shareholders and unsecured creditors. In meetings held on March 10, 2026, stakeholders demonstrated strong confidence in the strategic combination, which is set to create one of India's largest hospital networks. This approval clears a significant hurdle and moves the merger into its final stages, pending a sanction from the National Company Law Tribunal (NCLT).

Overwhelming Stakeholder Support

The NCLT-convened meetings confirmed broad-based support for the amalgamation. Equity shareholders approved the scheme with a commanding 96.68% majority. The proposal also received strong backing from the company's unsecured trade creditors. Out of 1,116 total creditors, 206 voted, with those in favor representing 80.07% of the total debt value, amounting to INR 68.04 crores. This decisive mandate from both shareholders and creditors is essential for the NCLT's final consideration of the merger scheme.

| Stakeholder Approval Summary (March 10, 2026) | | :--- | :--- | | Equity Shareholder Approval | 96.68% in favor | | Unsecured Creditor Approval (by value) | 80.0693% in favor | | Value of Creditor Votes in Favor | INR 68,03,98,379 | | Total Creditors Who Voted | 206 / 1116 |

The Merged Entity: A New Healthcare Giant

Upon completion, the merged entity will be named Aster DM Quality Care Limited. It is poised to become one of the top three hospital chains in India by both revenue and bed capacity. The combination brings together four prominent healthcare brands: Aster DM, CARE Hospitals, KIMSHEALTH, and Evercare, creating a diversified and powerful portfolio. The new entity will be jointly promoted by the Aster Promoters and global private equity firm Blackstone, reflecting a blend of clinical expertise and institutional growth capital.

The scale of the combined operations is substantial. The network will span 39 hospitals across nine states and 28 cities, supported by a workforce of over 36,300 employees and clinicians. This extensive geographic footprint is designed to enhance patient access to quality medical care across the country.

Strategic Rationale and Synergies

The merger is a strategic move to consolidate operations and unlock significant value. By integrating their networks, the companies aim to streamline shared services, centralize procurement, and improve overall operational efficiency. Management has projected potential EBITDA upside of 10-15% from these synergies. The combination is also expected to accelerate growth, enabling larger investments in brownfield and greenfield expansion projects, advanced medical technologies, and digital health platforms. This consolidation follows Aster DM Healthcare's strategic separation of its India and GCC businesses in April 2024, allowing for a more focused growth strategy within the Indian market.

Scale and Expansion Plans

The immediate combined bed capacity of Aster DM Quality Care Limited will be over 10,360 beds, based on figures from September 30, 2025. The new entity has ambitious expansion plans, aiming to increase its total capacity to approximately 14,715 beds in the coming years. This growth trajectory is intended to solidify its market-leading position and address the rising demand for healthcare services in India.

| Combined Entity Metrics | | :--- | :--- | | New Name | Aster DM Quality Care Limited | | Market Position | Top 3 Hospital Chain in India | | Initial Bed Capacity | 10,360+ | | Planned Bed Capacity | ~14,715 | | Hospital Network | 39 Hospitals | | Geographic Presence | 9 States, 28 Cities | | Combined Workforce | 36,307+ |

The Regulatory Journey

The path to this merger has involved several regulatory steps. Prior to the stakeholder votes, the transaction had already received crucial approvals from the Competition Commission of India (CCI) in April 2025 and 'No Objection' letters from the BSE and NSE. The NCLT's order in January 2026 to convene the shareholder and creditor meetings was another key milestone. With these approvals secured, the final step is the NCLT's sanction of the scheme. The company expects the entire process to conclude by the first quarter of the financial year 2026-27.

Market Impact and Next Steps

This merger is one of the largest consolidations in the Indian hospital sector, which was valued at approximately US$18.98 billion in 2023. It reflects a broader industry trend of scale-driven expansion, often fueled by private equity investment, as healthcare providers seek to enhance efficiency and market dominance. For investors and market observers, the key developments to monitor are the final NCLT hearing date and its subsequent ruling. Following the tribunal's sanction, the company will issue an official notification on the scheme's effectiveness and begin providing updates on the integration process and the realization of expected synergies.

Conclusion

With overwhelming support from its shareholders and creditors, Aster DM Healthcare is on the verge of completing its transformative merger with Quality Care India. The formation of Aster DM Quality Care Limited will create a formidable player in the Indian healthcare landscape, well-positioned for accelerated growth and enhanced operational performance. The final approval from the NCLT remains the last significant step in a well-progressed regulatory journey, with completion anticipated in the next quarter.